Authors:
REITER LA
MELVIN LS
CREAN GL
SHOWELL HJ
KOCH K
BIGGERS MS
CHENG JB
BRESLOW R
CONKLYN MJ
FARRELL CA
HADA WA
LAIRD ER
MARTIN JJ
MILLER GT
PILLAR JS
Citation: La. Reiter et al., 3-SUBSTITUTED-4-HYDROXY-7-CHROMANYLACETIC ACID-DERIVATIVES AS ANTAGONISTS OF THE LEUKOTRIENE B-4 (LTB4) RECEPTOR, Bioorganic & medicinal chemistry letters, 7(17), 1997, pp. 2307-2312
Authors:
RUSEK FW
FALKNER FC
JOHNSON DL
ROBINSON RP
MELVIN LS
Citation: Fw. Rusek et al., SYNTHESIS OF C-14 ISOTOPIC ISOMERS OF TENIDAP - A NOVEL ANTIINFLAMMATORY AGENT, Journal of labelled compounds & radiopharmaceuticals, 38(3), 1996, pp. 207-214
Citation: Xq. Xie et al., THE CONFORMATIONAL PROPERTIES OF THE HIGHLY SELECTIVE CANNABINOID RECEPTOR-LIGAND CP-55,940, The Journal of biological chemistry, 271(18), 1996, pp. 10640-10647
Authors:
MASAMUNE H
BRESLOW R
CHENG JB
CONKLYN MJ
EGGLER JF
MARFAT A
MELVIN LS
PILLAR JS
SHIRLEY JT
SHOWELL HJ
TICKNER JE
Citation: H. Masamune et al., SYNTHESIS AND IN-VITRO PROFILE OF 7-SUBSTITUTED QUINOLINE CHROMANOLS AS NOVEL, NONACIDIC LTB(4) ANTAGONISTS, Bioorganic & medicinal chemistry letters, 5(8), 1995, pp. 887-892
Authors:
ANDREWS EG
ANTOGNOLI GW
BRESLOW R
CARTA MP
CARTY TJ
CHAMBERS RJ
CHENG JB
COHAN VL
COLLINS JL
DAMON DB
DELEHUNT J
EGGLER JF
ESKRA JD
FREIERT KW
HADA WA
MARFAT A
MASAMUNE H
MELVIN LS
MULARSKI CJ
NACLERIO BA
PAZOLES CJ
PILLAR JS
RAPPACH LA
REICHE P
RUSEK FW
SHERMAN H
SHIRLEY JT
SWEENEY FJ
TICKNER JE
WATSON JW
WRIGHT CF
Citation: Eg. Andrews et al., SYNTHESIS AND PHARMACOLOGICAL PROFILE OF 2 NOVEL HETEROCYCLIC CHROMANOLS, CP-80,798 AND CP-85,958, AS POTENT LTD(4) RECEPTOR ANTAGONISTS, Bioorganic & medicinal chemistry letters, 5(13), 1995, pp. 1365-1370
Authors:
GRIFFITHS RJ
PETTIPHER ER
KOCH K
FARRELL CA
BRESLOW R
CONKLYN MJ
SMITH MA
HACKMAN BC
WIMBERLY DJ
MILICI AJ
SCAMPOLI DN
CHENG JB
PILLAR JS
PAZOLES CJ
DOHERTY NS
MELVIN LS
REITER LA
BIGGARS MS
FALKNER FC
MITCHELL DY
LISTON TE
SHOWELL HJ
Citation: Rj. Griffiths et al., LEUKOTRIENE B-4 PLAYS A CRITICAL ROLE IN THE PROGRESSION OF COLLAGEN-INDUCED ARTHRITIS, Proceedings of the National Academy of Sciences of the United Statesof America, 92(2), 1995, pp. 517-521
Authors:
SHOWELL HJ
PETTIPHER ER
CHENG JB
BRESLOW R
CONKLYN MJ
FARRELL CA
HINGORANI GP
SALTER ED
HACKMAN BC
WIMBERLY DJ
DOHERTY NS
MELVIN LS
REITER LA
BIGGERS MS
KOCH K
Citation: Hj. Showell et al., THE IN-VITRO AND IN-VIVO PHARMACOLOGICAL ACTIVITY OF THE POTENT AND SELECTIVE LEUKOTRIENE B-4 RECEPTOR ANTAGONIST CP-105696, The Journal of pharmacology and experimental therapeutics, 273(1), 1995, pp. 176-184
Authors:
KOCK K
NEWBORG MF
HANSON DC
COOPER K
SHEPARD RM
BIEHL ML
BIGGERS MS
RAMCHANDANI M
SCHUTTE G
SNYDER JR
FERRAINA RA
DONOVAN C
GUADLIANA MA
KOSTEK GJ
COLE SH
CONNOLLY MJ
SAWYER PS
TINGPO I
BLOCKER LW
MEISER BM
MELVIN LS
Citation: K. Kock et al., THE C-32 TRIACETYL-L-RHAMNOSE DERIVATIVE OF ASCOMYCIN - A POTENT, ORALLY-ACTIVE MACROLACTONE IMMUNOSUPPRESSANT, Journal of medicinal chemistry, 38(8), 1995, pp. 1255-1258
Authors:
KOCH K
MELVIN LS
REITER LA
BIGGERS MS
SHOWELL HJ
GRIFFITHS RJ
PETTIPHER ER
CHENG JB
MILICI AJ
BRESLOW R
CONKLYN MJ
SMITH MA
HACKMAN BC
DOHERTY NS
SALTER E
FARRELL CA
SCHULTE G
Citation: K. Koch et al., 4-PHENYLBENZYL)-4-HYDROXYCHROMAN-7-YL]CYCLOPENTANE CARBOXYLIC-ACID, AHIGHLY POTENT, SELECTIVE LEUKOTRIENE B-4 ANTAGONIST WITH ORAL ACTIVITY IN THE MURINE COLLAGEN-INDUCED ARTHRITIS MODEL()), Journal of medicinal chemistry, 37(20), 1994, pp. 3197-3199
Citation: Xq. Xie et al., CONFORMATIONAL-ANALYSIS OF THE PROTOTYPE NONCLASSICAL CANNABINOID CP-47,497, USING 2D NMR AND COMPUTER MOLECULAR MODELING, Journal of medicinal chemistry, 37(10), 1994, pp. 1418-1426
Citation: Wa. Hada et al., STRUCTURE OF 3,4-DIHYDROXY-2-THIOPHENECARBOXYLIC ACID ETHYL-ESTER IN THE CRYSTAL AND SOLUTION STATES, Tetrahedron letters, 34(51), 1993, pp. 8229-8232
Authors:
COMPTON DR
RICE KC
DECOSTA BR
RAZDAN RK
MELVIN LS
JOHNSON MR
MARTIN BR
Citation: Dr. Compton et al., CANNABINOID STRUCTURE-ACTIVITY-RELATIONSHIPS - CORRELATION OF RECEPTOR-BINDING AND INVIVO ACTIVITIES, The Journal of pharmacology and experimental therapeutics, 265(1), 1993, pp. 218-226